Comorbidity of Anxiety and Affective Disorders as Neuropsychiatric and Evolutionary Problem (A New Concept)
نویسنده
چکیده
Although the comorbidity issues in psychiatry have received a wide recognition for at least the last 20 years and caused a great stream of publications all over the world, many questions remain unanswered. It concerns as phenomenon of comorbidity itself, as plausible explanation of its origin. Little is known, why in some patients the so-called pure (non comorbid) psychopathological states present (i.e. pure depression or anxiety), while in other cases comorbidity between affective and anxiety disorders exists. At present, factors determining the comorbidity between depression and anxiety disorders unfortunately remain unknown. The principal and unexplained phenomenon in comorbidity issues concern the asymmetry in comorbidity between affective and anxiety disorders (Table 1). Indeed, patients with primary diagnosis of anxiety disorder have more frequent comorbidity with depression (4862%) than vice versa (10-20%, Table 1). (Kendler et al., 1992; Kessler, 1999; Kessler et al., 1994; 1995; 1996, 1999; Roy-Byrne et al., 2000). These findings haven’t obtained any plausible explanation yet, and comorbidity studies including description of comorbid disorders and statistical evaluation of risk for their development didn’t give us any clue (except for genetic origin or predisposing trigger factors) for solving these issues. On the other hand, neuropsychological or neuropsychiatric mechanisms have been rarely used in order to explain any psychopathological phenomena, and strong demarcation line, unfortunately still exists between neuropsychology and general psychopathology, although the both disciplines represent two domains of neuroscience. It concerns the problems of localization and lateralization of cerebral functions as in so-called normal, as in pathological states, although a great progress has been achieved for the last forty years in realms relevant to these problems. Moreover, epilepsy (especially temporal lobe epilepsy, TLE) seems to represent a useful model for profound understanding of unresolved psychopathological issues, including comorbidity between anxiety and depression.
منابع مشابه
P167: Effect of Mitochondrial Mutation on Depression and Anxiety
Mitochondria are membrane-enclosed organelle found in most eukaryotic cells, which known as power house in cells. This organelle transforms energy into forms that are usable by the cell. The most common psychiatric disorders such as depression and anxiety can be linked to mitochondrial disorders. Furthermore, mutations of mitochondrial or nuclear DNA (mtDNA and nDNA, respectively) have been lin...
متن کاملهمبودی اختلالهای اضطرابی و افسردگی: ظهور درمان فراتشخیصی شناختی رفتاری
Comorbidity of anxiety and depression disorders in most epidemiological studies has been reported between 40% and 80%, and these conditions impose many costs directly and indirectly on societies. High comorbidity of these disorders makes the use of specific protocols of cognitive behavioral therapy for these co-occurrence disorders, may not be affordable. Attention to the issue of the comorbidi...
متن کاملO16: How Do Concepts of Evolutionary Psychology and Evolutionary Psychiatry Explain Anxiety Disorders?
Our ancestors without fear, worry and anxiety are not our ancestors, as organisms without defense systems were extinct. Therefore, while behavior such as fear and anxiety are useful to prevent harm, the exaggerated form, that is, anxiety disorders, has more costs than benefits. Likewise, while a panic attack is a normal and useful response in the face of life-threatening danger, a panic disorde...
متن کاملFingolimod shows antiepileptogenic and anti anxiety/depressive effects in Wag/Rij rats, a well established model of absence epilepsy and neuropsychiatric comorbidities
Fingolimod (FTY720), a sphingosine-1-phosphate receptor (S1PR) modulator, was the first oral therapy approved by US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of relapsing-remitting multiple sclerosis[1]. To date, fingolimod has not been studied in epilepsy models; however, a recent study performed in the lithium-pilocarpine rat model of SE (status ...
متن کاملO4: Trans-Diagnostic CBT and Comorbidity in the Anxiety Disorders
Recent research from a number of clinical trials has shown that Transdiagnostic Cognitive-Behavioral Therapy is efficacious, having shown comparable effects on primary anxiety disorder diagnoses as traditional diagnosis-specific CBT, and highly economical for treatment providers. However, a majority of anxiety disorder patients present with two or more “comorbid” diagnoses at once. Given that T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012